Blood Collection Sub-Study for CRC Screening in Individuals 45-49 at Average Risk for CRC.
NCT ID: NCT03741166
Last Updated: 2021-05-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
871 participants
OBSERVATIONAL
2018-11-08
2019-04-05
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
An Evaluation of a Multi-target Stool DNA (Mt-sDNA) Test, Cologuard, for CRC Screening in Individuals Aged 45-49 and at Average Risk for Development of Colorectal Cancer: Act Now
NCT03728348
Blood and Stool Sample Collection in Subjects Participating in Colorectal Cancer Screening: Act Bold
NCT03821948
Blood and Stool Sample Collection in Subjects With a Diagnosis of Colorectal Cancer or Colorectal Lesion: Act Fast
NCT03789162
Blood Collection Sub-Study of Exact Sciences Protocol 2019-01: "Clinical Validation of an Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test, For Colorectal Cancer Screening BLUE-C"
NCT04144751
Exact CRC Screening Test: Stool Sample Collection Study to Support Assay Validation Testing
NCT01600209
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Subject aged 45-49 with Average CRC Risk
Subjects will be men and women, 45-49 years of age, who enroll in Exact Sciences Protocol 2018-10. Subjects will provide a blood sample at time of enrollment.
Blood Sample Collection
Subjects participating in the study will have blood drawn at enrollment.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Blood Sample Collection
Subjects participating in the study will have blood drawn at enrollment.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Subject is willing and able to provide a blood sample.
3. Subject is willing and able to sign informed consent.
Exclusion Criteria
45 Years
49 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Exact Sciences Corporation
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Thomas Imperiale
Role: PRINCIPAL_INVESTIGATOR
Indiana University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mayo Clinic Arizona
Phoenix, Arizona, United States
Ventura County Gastroenterology
Camarillo, California, United States
Alliance Research Centers
Laguna Hills, California, United States
Focilmed
Oxnard, California, United States
Desert Oasis Healthcare Medical Group
Palm Springs, California, United States
Gastroenterology Associates of Fairfield County
Bridgeport, Connecticut, United States
Yale University Section of Digestive Diseases and Liver Diseases
New Haven, Connecticut, United States
Precision Clinical Research, LLC
Lauderdale Lakes, Florida, United States
Northshore University Health System Evanston Hospital
Evanston, Illinois, United States
DM Clinical Research- Southwest Gastroenterology
Oak Lawn, Illinois, United States
Deaconess Clinic- Mt. Pleasant
Evansville, Indiana, United States
Deaconess Clinic- Gateway
Newburgh, Indiana, United States
Johnson County ClinTrials, LLC
Lenexa, Kansas, United States
New Orleans Research Institue
Metairie, Louisiana, United States
Delta Research Partners, LLC
Monroe, Louisiana, United States
Louisiana Research Center
Shreveport, Louisiana, United States
Investigative Clinical Research
Annapolis, Maryland, United States
Centennial Medical Group
Elkridge, Maryland, United States
Capitol Research
Rockville, Maryland, United States
Commonwealth Clinical Studies
Brockton, Massachusetts, United States
Mayo Clinic Rochester
Rochester, Minnesota, United States
United Medical Associates
Binghamton, New York, United States
Asheville Gastroenterology Associates
Asheville, North Carolina, United States
Charlotte Gastroenterology & Hepatology, PLLC
Charlotte, North Carolina, United States
Wilmington Gastroenterology Associates
Wilmington, North Carolina, United States
University Hospitals Cleveland Medical Center
Cleveland, Ohio, United States
Great Lakes Gastroenterology Research, LLC
Mentor, Ohio, United States
Comprehensive Internal Medicine, Inc.
Wooster, Ohio, United States
Family Practice Center of Wooster, Inc./Clinical Trial Developers
Wooster, Ohio, United States
Gastroenterology Associates, PA
Greenville, South Carolina, United States
Gastro One
Germantown, Tennessee, United States
Quality Medical Research, PLLC
Nashville, Tennessee, United States
Austin Regional Clinic
Austin, Texas, United States
University of Texas Health Science Center- McGovern Medical School
Houston, Texas, United States
DM Clinical Research- PCP for Life
Houston, Texas, United States
Virginia Gastroenterology Institute
Suffolk, Virginia, United States
Wisconsin Center for Advanced Research
Milwaukee, Wisconsin, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2018-10B
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.